Momota Tablets (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 tablet (0.5mg) once daily. Swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or elderly patients. The recommended dose in patients with hepatic impairment has not been established because no data are available on the administration of this medicine to these patients.

This medicine must not be handled by women, especially those who are pregnant or may become pregnant. This is because the medicine can be absorbed through the skin and pose a risk of causing abnormalities in male fetuses. Children should also be cautioned against touching broken or crushed pieces of this medicine. Additionally, it should not be administered to children or women under 18 years of age. Men planning to conceive should administer this medicine under the careful judgment of a physician as it may affect reproductive ability. Patients with high residual urine volume or severe urinary flow reduction and patients with liver dysfunction should also exercise caution when using this medicine. In particular, patients with liver dysfunction should use this medicine more carefully as its half-life is prolonged. Patients taking strong CYP3A4 inhibitors for a long time should be cautious as the blood concentration of this medicine may increase. While taking this medicine, sexual side effects such as erectile dysfunction, decreased libido, and ejaculation disorders may occur and these symptoms may persist even after discontinuation. There have also been reports of breast-related adverse reactions such as gynecomastia and breast tenderness. This medicine is used for the treatment of benign prostatic hyperplasia and male pattern baldness, and caution is necessary in interpreting PSA test results, as PSA levels may decrease after administration. Patients taking this medicine should undergo regular prostate cancer screening and carefully monitor changes in PSA levels. While a clear association with male breast cancer has not been established, any changes in the breasts should be reported to a physician immediately. This medicine may affect reproductive capacity, so changes in the characteristics of sperm should be observed during long-term administration. Patients taking this medicine should refrain from donating blood for at least 6 months after the last dose. While the potential for affecting driving or machinery operation is low, patients with heart failure need to be cautious regarding potential adverse reactions related to this medicine. There is no specific antidote in case of overdose, so appropriate supportive treatment is required. This medicine should be stored out of reach of children, and kept in its original container to prevent misuse and degradation of quality.

• Erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorder
• dizziness
• rash

This medicine should be stored in a sealed container to prevent exposure to air or moisture. It is also recommended to keep the medicine at room temperature between 1 to 30 degrees Celsius. This will help maintain the medicine's effectiveness over time.

Appearance

Light yellow oval film-coated tablet

Package unit

- - 30 Tablets/PTP [10 Tablets/PTP x 3]